Cargando…

Molecular Mechanism Pathways of Natural Compounds for the Treatment of Non-Alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the world, and its incidence continues to increase each year. Yet, there is still no definitive drug that can stop its development. This review focuses mainly on lipotoxicity, oxidative stress, inflammation, and in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Xiaolei, Song, Jiayu, Zhou, Kaixuan, Zi, Xue, Sun, Bin, Bao, Huiwei, Li, Lijing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419790/ https://www.ncbi.nlm.nih.gov/pubmed/37570615 http://dx.doi.org/10.3390/molecules28155645

Ejemplares similares

Molecular Mechanistic Pathways Targeted by Natural Compounds in the Prevention and Treatment of Diabetic Kidney Disease
por: Zhou, Kaixuan, et al.
Publicado: (2022)

Sepsis‑induced cardiac dysfunction and pathogenetic mechanisms (Review)
por: Song, Jiayu, et al.
Publicado: (2023)

Molecular mechanism of alcoholic fatty liver
por: Rasineni, Karuna, et al.
Publicado: (2012)

Terpenoids: Natural Compounds for Non-Alcoholic Fatty Liver Disease (NAFLD) Therapy
por: Yao, Pengyu, et al.
Publicado: (2022)

Molecular pathways in non-alcoholic fatty liver disease
por: Berlanga, Alba, et al.
Publicado: (2014)

Component-Effect Relationship between HPLC Fingerprints and Lipid-Lowering Activity of Buyang Huanwu Decoction
por: Li, Lijing, et al.
Publicado: (2022)

Investigation on the mechanism of Ginkgo Folium in the treatment of Non-alcoholic Fatty Liver Disease by strategy of network pharmacology and molecular docking
por: Sun, Yuanfang, et al.
Publicado: (2023)

The Natural Course of Non-Alcoholic Fatty Liver Disease
por: Calzadilla Bertot, Luis, et al.
Publicado: (2016)

The natural course of non-alcoholic fatty liver disease
por: Seval, Guldane Cengiz, et al.
Publicado: (2020)

Hepatoprotective Effect and Molecular Mechanisms of Hengshun Aromatic Vinegar on Non-Alcoholic Fatty Liver Disease
por: Zhu, Shenghu, et al.
Publicado: (2020)

Association between hemoglobin glycation index and non-alcoholic fatty liver disease
por: Xing, Yuling, et al.
Publicado: (2023)

Natural Compounds: A Potential Treatment for Alcoholic Liver Disease?
por: Yan, Junbin, et al.
Publicado: (2021)

The Effect of Bioactive Aliment Compounds and Micronutrients on Non-Alcoholic Fatty Liver Disease
por: Munteanu, Camelia, et al.
Publicado: (2023)

Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
por: Ipsen, David Højland, et al.
Publicado: (2018)

The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms
por: JASIRWAN, Chyntia Olivia Maurine, et al.
Publicado: (2019)

Identification of disease-related genes and construction of a gene co-expression database in non-alcoholic fatty liver disease
por: Ye, Hua, et al.
Publicado: (2023)

The Role of the Transsulfuration Pathway in Non-Alcoholic Fatty Liver Disease
por: Werge, Mikkel Parsberg, et al.
Publicado: (2021)

Antitussive and Anti-inflammatory Dual-active Agents Developed from Natural Product Lead Compound 1-Methylhydantoin
por: Xu, Yang, et al.
Publicado: (2019)

The molecular basis of the associations between non-alcoholic fatty liver disease and colorectal cancer
por: Qiu, Ting, et al.
Publicado: (2022)

Volatomic analysis identifies compounds that can stratify non-alcoholic fatty liver disease
por: Sinha, Rohit, et al.
Publicado: (2020)

Pediatric Non-Alcoholic Fatty Liver Disease: Nutritional Origins and Potential Molecular Mechanisms
por: Mandala, Ashok, et al.
Publicado: (2020)

Revisiting the Role of Natural Killer Cells in Non-Alcoholic Fatty Liver Disease
por: Martínez-Chantar, María Luz, et al.
Publicado: (2021)

Natural flavonoids: Potential therapeutic strategies for non-alcoholic fatty liver disease
por: Tan, Panli, et al.
Publicado: (2022)

Editorial: Natural products as potential therapies for non-alcoholic fatty liver disease
por: Ibrahim, Islam A. A. E. H., et al.
Publicado: (2023)

Identification and validation of disulfidptosis-associated molecular clusters in non-alcoholic fatty liver disease
por: Yu, Xiaoxiao, et al.
Publicado: (2023)

The Role of Notch Signaling Pathway in Non-Alcoholic Fatty Liver Disease
por: Xu, Hao, et al.
Publicado: (2021)

Detailed Molecular Mechanisms Involved in Drug-Induced Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: An Update
por: Di Pasqua, Laura Giuseppina, et al.
Publicado: (2022)

Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease()
por: Khambu, Bilon, et al.
Publicado: (2018)

Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
por: Foroughi, Mehdi, et al.
Publicado: (2016)

Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment
por: Guo, Xiangyu, et al.
Publicado: (2022)

Alcohol? Not for Non-alcoholic Fatty Liver Disease Patients
por: Cainelli, Francesca, et al.
Publicado: (2020)

Establishment of the Tree Shrew as an Alcohol-Induced Fatty Liver Model for the Study of Alcoholic Liver Diseases
por: Xing, Huijie, et al.
Publicado: (2015)

Therapeutic Potential of Natural Plants Against Non-Alcoholic Fatty Liver Disease: Targeting the Interplay Between Gut Microbiota and Bile Acids
por: Sun, QinMei, et al.
Publicado: (2022)

Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids
por: Orešič, Matej, et al.
Publicado: (2013)

Aurantio-Obtusin Attenuates Non-Alcoholic Fatty Liver Disease Through AMPK-Mediated Autophagy and Fatty Acid Oxidation Pathways
por: Zhou, Fei, et al.
Publicado: (2022)

Effects of beer, wine, and baijiu consumption on non-alcoholic fatty liver disease: Potential implications of the flavor compounds in the alcoholic beverages
por: Zhou, Yabin, et al.
Publicado: (2023)

Molecular links between non-alcoholic fatty liver disease and hepatocellular carcinoma
por: Raza, Sana, et al.
Publicado: (2019)

Current insights in molecular characterization of non-alcoholic fatty liver disease and treatment
por: Che, Wensheng, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease
por: Sattar, Naveed, et al.
Publicado: (2014)

Lipophagy and Alcohol-Induced Fatty Liver
por: Yang, Li, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8sdukra4mca1nsejus6oea9pbj